Unbound MEDLINE

Novel Environment and GABA Agonists Alter ERPs in NMDA NR1 Hypomorphic and Wild-type Mice. The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] Journal article

 
Bodarky CL, Halene TB, Ehrlichman RS, Banerjee A, Ray R, Hahn CG, Jonak G, Siegel SJ 
Novel Environment and GABA Agonists Alter ERPs in NMDA NR1 Hypomorphic and Wild-type Mice. [JOURNAL ARTICLE]
J Pharmacol Exp Ther 2009 Jul 14.


Background: Clinical and experimental data suggest dysregulation of NMDAR-mediated glutamatergic pathways in schizophrenia. The interaction between NMDAR-mediated abnormalities and the response to novel environment have not been studied.
Methods: Mice expressing 5-10% of normal NR1 subunits (NR1(neo)-/-) were compared to wild-type littermates for P20 and N40 auditory ERPs. Groups were tested for habituation within and across five testing sessions, with novel environment tested during a sixth session. Subsequently, we examined the effects of a GABAA positive allosteric modulator (chlordiazepoxide) and a GABAB receptor agonist (baclofen) as potential interventions to normalize aberrant responses.
Results: There was a reduction in P20, but not N40 amplitude within each habituation day. While there was no amplitude or gating change across habituation days, there was a reduction in P20 and N40 amplitude and gating in the novel environment. There was no difference between genotypes for N40. Only NR1(neo)-/- mice had reduced P20 in the novel environment. Chlordiazepoxide increased N40 amplitude in wild-type mice, while baclofen increased P20 amplitude in NR1(neo)-/- mice.
Conclusions: As noted in previous publications, the pattern of ERPs in NR1(neo)-/- mice does not recapitulate abnormalities in schizophrenia. Additionally, reduced NR1 expression does not influence N40 habituation, but does affect P20 in a novel environment. Thus, the pattern of P50 but not N100 in human studies may relate to subjects' reactions to unfamiliar environments. Additionally, NR1 reduction decreased GABAA receptor-mediated effects on ERPs while causing increased GABAB receptor-mediated effects. Future studies will examine changes in GABA receptor subunits following reductions in NR1 expression.



More from this journal
  
Advertise on this site.